Filing Overview
Registrant: Pono Capital Two, Inc. (Nasdaq: PTWO, PTWOU, PTWOW). Report date: May 18, 2023; signed May 19, 2023. The filing concerns SBC Medical Group Holdings Incorporated, the counterparty to Pono’s proposed business combination. It is not an operating-results filing for SBC.
Material Transaction
On May 18, 2023, Pono and SBC entered into a Note Purchase Agreement in connection with the amended merger agreement dated April 26, 2023. Pono agreed to issue SBC a $1.0 million convertible promissory note, subject to customary closing conditions.
- The closing was required to occur no later than May 31, 2023, subject to satisfaction or waiver of applicable conditions.
- SBC was to fund $1.0 million by wire transfer and receive the note.
- The note bears no interest unless required by law and may be prepaid at any time.
- Immediately before completion of the business combination, the principal amount would automatically convert into 100,000 shares of Pono Class A common stock, based on a $10.00 conversion price, subject to customary stock-split adjustments.
- The shares are being issued under the Securities Act Section 4(a)(2) private-placement exemption.
- SBC agreed to enter into a lock-up agreement for the converted shares. The lock-up generally ends upon the earliest of six months after the business-combination closing, certain qualifying third-party transactions, or specified share-price triggers, with staged releases tied to $13.00, $15.00, and $17.00 price levels.
- An event of default could accelerate repayment of the note at SBC’s option.
Financial Metrics and Liquidity
The filing does not provide SBC’s or Pono’s revenue, profit, cash flow, operating margins, cash balance, debt ratios, or other operating financial metrics. The disclosed financing is a $1.0 million principal obligation that is intended to convert into equity immediately before the merger, subject to the note’s terms and completion of the business combination.
Changes Versus Prior Period
No comparable-period financial results are presented. The material change disclosed is the creation of the $1.0 million convertible note obligation and the related potential issuance of 100,000 shares in connection with the proposed merger.
Outlook, Risks, and Contingencies
The proposed business combination remains subject to conditions, including Pono stockholder approval. The filing does not provide formal financial guidance. Management identifies risks including failure or delay of the merger, termination of the merger agreement, litigation, higher-than-expected redemptions, failure to satisfy Nasdaq listing requirements, disruption to SBC’s business, the need for additional capital, uncertainty regarding SBC’s future revenue and capital expenditures, and uncertainty regarding the anticipated financial benefits of the transaction.
The filing states that Pono intends to file proxy materials with the SEC. The Form 8-K itself is not an offer to sell securities or a solicitation of votes.
Investor Verification Points
- Verify whether the note purchase closed by May 31, 2023 and whether SBC funded the $1.0 million.
- Confirm whether the proposed business combination was completed, terminated, or amended in subsequent filings.
- Review the note, merger agreement, lock-up agreement, and later proxy materials for final conversion, share issuance, redemption, and capitalization terms.
- Assess SBC’s operating results, liquidity, debt, and cash-flow information in the proxy statement and subsequent SEC filings; those figures are not provided here.
- Monitor any note default, repayment, conversion, or changes to the transaction’s conditions and timeline.